{"id":4534,"date":"2022-07-22T06:28:30","date_gmt":"2022-07-22T06:28:30","guid":{"rendered":"https:\/\/www.sarmsthailand.com\/?post_type=product&p=4534"},"modified":"2026-08-12T05:13:57","modified_gmt":"2026-08-12T05:13:57","slug":"ac-262-accadrine","status":"publish","type":"product","link":"https:\/\/www.sarmsthailand.com\/th\/product\/ac-262-accadrine\/","title":{"rendered":"AC-262 (Accadrine) 10 mg\/ml (30ml)"},"content":{"rendered":"
\n

Buy AC-262 Accadrine SARM in Thailand<\/h2>\n

AC-262 Accadrine comes in a 30ml liquid bottle containing 10 mg per ml. The compound\u2019s full development code is AC-262536, although it is usually shortened to AC-262 within the SARM market.<\/p>\n

AC-262536 is an investigational selective androgen receptor modulator originally developed by Acadia Pharmaceuticals. It was researched for its tissue-selective interaction with androgen receptors and its potential anabolic activity in muscle.<\/p>\n

\n

AC-262 Product Specifications<\/h2>\n
\n\n\n\n\n\n\n\n\n
Product<\/th>\nAC-262 Accadrine<\/td>\n<\/tr>\n
Full development code<\/th>\nAC-262536<\/td>\n<\/tr>\n
Concentration<\/th>\n10 mg per ml<\/td>\n<\/tr>\n
Bottle size<\/th>\n30ml<\/td>\n<\/tr>\n
Format<\/th>\nLiquid<\/td>\n<\/tr>\n
Compound class<\/th>\nInvestigational selective androgen receptor modulator<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

What Is AC-262 Accadrine?<\/h2>\n

AC-262536 is a nonsteroidal SARM that acts as a partial agonist of the androgen receptor. It was designed to produce tissue-selective activity rather than the full androgen-receptor response associated with traditional androgenic compounds.<\/p>\n

The compound is usually marketed as AC-262 or Accadrine. These names refer to AC-262536 and should not be confused with unrelated compounds that use similar research codes.<\/p>\n

Selective Androgen Receptor Research<\/h2>\n

Early laboratory research found that AC-262536 bound selectively to the androgen receptor without significant affinity for the other receptors included in the study. This selectivity was a central part of its development as a novel SARM.<\/p>\n

Researchers described AC-262536 as a partial androgen-receptor agonist, meaning it activated the receptor differently from a full agonist such as testosterone. This pharmacological profile helped distinguish AC-262536 from conventional steroidal androgens.<\/p>\n

Anabolic Activity Research<\/h2>\n

In a two-week preclinical study, AC-262536 significantly improved anabolic measurements in androgen-deficient animal models. Researchers reported increased growth of androgen-responsive muscle tissue together with suppression of elevated luteinizing hormone levels.<\/p>\n

The same research found substantially weaker activity in prostate and seminal-vesicle tissue than testosterone. The researchers concluded that AC-262536 demonstrated beneficial anabolic effects together with tissue-selective androgen-receptor activity.<\/p>\n

Why AC-262 Is Known as Accadrine<\/h2>\n

Accadrine is the market name most commonly associated with AC-262536. Customers may encounter the compound listed as AC-262, AC-262536 or Accadrine, but all three names should identify the same SARM.<\/p>\n

Interest in AC-262 is connected to its early research involving androgen-receptor selectivity, anabolic activity and comparatively weaker stimulation of certain androgen-sensitive tissues.<\/p>\n

Research Status<\/h2>\n

Available published research on AC-262536 is primarily preclinical. The findings helped establish the compound\u2019s SARM classification but do not guarantee a specific amount of muscle growth, strength improvement or body-composition change for an individual.<\/p>\n

AC-262 and Tested Sport<\/h2>\n

AC-262536 falls within the selective androgen receptor modulator class prohibited under the World Anti-Doping Agency Prohibited List. Athletes subject to anti-doping rules should avoid exposure to Accadrine.<\/p>\n

Independent Information Sources<\/h2>\n